Consensus

The company is covered by various German and international financial analysts. The most recent analyst consensus is given below. It is based on the estimates of 19 major banks consulted by Vara Research.

This website may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Consensus earnings estimates are based on earnings projections made by securities analysts who cover Bayer. Any opinions, forecasts, estimates, projections or predictions regarding Bayer's performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Bayer or its management. Bayer does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. Bayer assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.

Q2 2016 Consensus Estimates
in € millionAverage
Sales12,118
EBITDA before special items
2,940
EBIT before special items2,161
EBIT2,058
Pre-tax Income1,765
Net Income
1,349
EPS (€ / share) - continuing operations1.58
Core EPS (€ / share) - continuing operations2.02
Income from discontinued operations after tax
47


Provided by:

Disclaimer:

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.

Last updated: July 15, 2016 Copyright © Bayer AG